Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Revvity Inc. (RVTY) trades at a P/S ratio of 5.8×. Over the past ten years it has ranged from 2.2× (February 2016) to 6.7× (January 2021); the current reading is higher than 96% of that period. That is above the Diagnostics & Research industry median of 4.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 3.9× (20.61%)
FY2024 5.0× (0.67%)
FY2023 5.0× (6.88%)
FY2022 5.4× (11.89%)
FY2021 6.1× 1.55%
FY2020 6.0× 61.01%
FY2019 3.7× 19.37%
FY2018 3.1× (13.10%)
FY2017 3.6× 31.19%
FY2016 2.7× (4.23%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 4.3× 26.28%
Mar 2026 3.4× (14.48%)
Dec 2025 3.9× 9.80%
Sep 2025 3.6× (11.47%)
42 more quarters

Against its own ten years

Low 2.2× High 6.7×
Ten-year median 3.9×
Current reading's percentile 96

P/S ratio against peers

Company P/S ratio
ICLR ICON PLC compare 1.6×
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
CRL Charles River Laboratories International, Inc. compare 3.6×
QGEN QIAGEN N.V. compare 4.5×
RVTY Revvity Inc. 5.8×
MEDP Medpace Holdings, Inc. compare 6.3×
GH Guardant Health, Inc. compare 17.8×
TWST Twist Bioscience Corporation compare 19.2×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on RVTY